Showing results (71-80 of 435) with videos related to
Sort By:
Pageof 44
Current Hematologic Malignancy Reports|May 8, 2010
Improving induction therapy in multiple myelomaAjay Nooka, Charise Gleason, Sagar LonialJournal of the National Comprehensive Cancer Network : JNCCN|January 12, 2013
Induction therapy for newly diagnosed multiple myelomaSagar Lonial, Jesus F San MiguelJournal of the National Comprehensive Cancer Network : JNCCN|November 3, 2009
Supportive therapies in multiple myelomaCharise Gleason, Ajay Nooka, Sagar LonialCancer Journal (Sudbury, Mass.)|December 17, 2009
The importance of complete response in outcomes in myelomaAjay Nooka, Jonathan Kaufman, Sagar LonialAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2022
Moving Toward a Cure for MyelomaMaría-Victoria Mateos, Ajay K Nooka, Sarah M LarsonAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 22, 2026
Smoldering Multiple Myeloma: From Clinical to Immunogenomic Risk Stratification and Therapeutic Implications of Early InterventionNizar J Bahlis, María V Mateos, Ajay K NookaBlood Cancer Journal|January 6, 2019
Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I StudyJonathan L Kaufman, Roberto Mina, Andrzej J Jakubowiak, et al.Clinical Lymphoma, Myeloma & Leukemia|August 22, 2020
Phase 1 Trial Evaluating Vorinostat Plus Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple MyelomaJonathan L Kaufman, Roberto Mina, Jatin J Shah, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantationAjay K Nooka, Heather R Johnson, Jonathan L Kaufman, et al.Leukemia Research|May 18, 2010
Combined proteasome and histone deacetylase inhibition: A promising synergy for patients with relapsed/refractory multiple myelomaSundar Jagannath, Meletios A Dimopoulos, Sagar LonialPageof 44